This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

AbCellera

Profile

AbCellera partners to discover and develop next-generation therapeutic antibodies. Our team integrates end-to-end capabilities in proprietary immunizations, microfluidics, genomics, and computation to develop innovative strategies that overcome tough challenges and advance discovery programs. We quickly deliver large and diverse panels of high-quality antibodies from any species, including humans.



We're bringing you

  • From Patient Sample to Antibody Lead in Three Weeks: A Real-Time Response to COVID-19

    On Demand
  • From Patient Sample to Antibody Lead in Three weeks: A Real-Time Response to COVID-19

    3:15pm